Related news from |
Sun, 12 May 2024 12:22:42 +0000 |
Analysts Are Upgrading BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results
BioLife Solutions, Inc. ( NASDAQ:BLFS ) just released its quarterly report and things are looking bullish. Revenue...
|
Fri, 10 May 2024 16:37:13 +0000 |
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript May 9, 2024 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.26. BLFS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the BioLife Solutions First […]
|
Thu, 09 May 2024 22:05:07 +0000 |
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
BioLife Solutions (BLFS) delivered earnings and revenue surprises of 26.92% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
|
Thu, 09 May 2024 20:03:00 +0000 |
BioLife Solutions Reports First Quarter 2024 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and the broader biopharma markets, today announced financial results for the three months ended March 31, 2024 and affirmed its revenue guidance for 2024.
|
Thu, 02 May 2024 14:01:13 +0000 |
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
BioLife Solutions (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
|
Tue, 30 Apr 2024 20:12:00 +0000 |
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business
|
Thu, 18 Apr 2024 15:00:49 +0000 |
Insider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...
BioLife Solutions Inc (NASDAQ:BLFS) Chief Marketing Officer Todd Berard has sold 10,000 shares of the company on April 15, 2024, according to a recent SEC Filing.
|
Thu, 18 Apr 2024 12:05:00 +0000 |
BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and the broader biopharma markets, today announced that it has completed the divestiture of its wholly owned subsidiary Global Cooling, Inc. ("GCI" or "Stirling").
|
Fri, 29 Mar 2024 10:39:17 +0000 |
Investors in BioLife Solutions (NASDAQ:BLFS) have unfortunately lost 49% over the last three years
BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders should be happy to see the share price up 14% in the last quarter...
|
Wed, 27 Mar 2024 20:37:08 +0000 |
Corporate Insiders Are Selling These 10 Small-Cap Stocks
In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders Are Selling These 5 Small-Cap Stocks. When the inflation crisis started and the Federal Reserve began raising interest rates, investors were quick to exit small-cap stocks which are deemed […]
|
Thu, 14 Mar 2024 06:15:04 +0000 |
Director Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS)
BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sale according to a recent SEC filing.
|
Wed, 13 Mar 2024 05:50:09 +0000 |
Insider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS)
BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sell according to the latest SEC filings.
|
Fri, 08 Mar 2024 18:58:42 +0000 |
When Will BioLife Solutions, Inc. (NASDAQ:BLFS) Become Profitable?
BioLife Solutions, Inc. ( NASDAQ:BLFS ) is possibly approaching a major achievement in its business, so we would like...
|
Mon, 04 Mar 2024 13:03:00 +0000 |
BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that Roderick de Greef, Chief Executive Officer, and Troy Wichterman, Chief Financial Officer, will present and meet with current and prospective investors at the following March Investor Conferences.
|
Sat, 02 Mar 2024 13:16:17 +0000 |
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript February 29, 2024 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.36. BioLife Solutions, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
|
Fri, 01 Mar 2024 11:02:57 +0000 |
Q4 2023 BioLife Solutions Inc Earnings Call
Q4 2023 BioLife Solutions Inc Earnings Call
|
Thu, 29 Feb 2024 21:03:00 +0000 |
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the fourth quarter and year ended December 31, 2023, and introduces 2024 revenue guidance.
|
Tue, 20 Feb 2024 13:03:00 +0000 |
BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2023 financial results will be released after market close on Thursday, February 29, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and gi
|
Sat, 17 Feb 2024 12:27:45 +0000 |
Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?
While BioLife Solutions, Inc. ( NASDAQ:BLFS ) might not have the largest market cap around , it saw a significant share...
|
Fri, 19 Jan 2024 10:10:28 +0000 |
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 36% Undervaluation?
Key Insights The projected fair value for BioLife Solutions is US$26.50 based on 2 Stage Free Cash Flow to Equity...
|